PharmaShots | Incisive News in 3 Shots

Subscribe Now

Sciwind Biosciences

Sciwind Biosciences Initiates the Patient Dosing of Ecnoglutide (XW003) in P-III Clinical Trials for the Treatment of Type 2 Diabetes in China

Sciwind Biosciences Initiates the Patient Dosing of Ecnoglutide (XW003) in P-III Clinical Trials for the Treatment of Type 2 Diabe...

January 31, 2023

Sciwind Biosciences Reports P-IIb Trial Interim Results of XW003 (ecnoglutide) for the Treatment of Obesity

Sciwind Biosciences Reports P-IIb Trial Interim Results of XW003 (ecnoglutide) for the Treatment of Obesity

October 28, 2022

Sciwind Biosciences Initiates the First Patient Dosing of XW014 in P-I for the Treatment of Obesity and Type 2 Diabetes

Sciwind Biosciences Initiates the First Patient Dosing of XW014 in P-I for the Treatment of Obesity and Type 2 Diabetes

October 10, 2022

Sciwind Biosciences Entered into a Research Collaboration with SynerK to Develop Novel siRNA Therapies for Liver and Metabolic Diseases

Sciwind Biosciences Entered into a Research Collaboration with SynerK to Develop Novel siRNA Therapies for Liver and Metabolic Dis...

September 27, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us